Histone Deacetylase Inhibitors as Cancer Therapeutics
Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."
Included in series
Advances in Cancer Research
Advances in Cancer Research
Hardbound, 288 Pages
Published: November 2012
Imprint: Academic Press
ISBN: 978-0-12-394387-3
Contents
- Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins
Brian Gabrielli and Mellissa Brown - Mechanisms of Resistance to Histone Deacetylase Inhibitors
Ju-Hee Lee, Megan L. Choy and Paul A. Marks - HDAC Inhibitors: Roles of DNA Damage and Repair
Carine Robert and Feyruz V. Rassool - HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer
David J. McConkey, Matthew White, and Wudan Yan - Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Anti-Tumor Activity
Geoffrey M Matthews, Andrea Newbold and Ricky W. Johnstone - Histone Deacetylase Inhibitors and Rational Combination Therapies
Steven Grant - HDAC Inhibitors and Chaperone Function
Rekha Rao, Siddhartha Ganguly, Suman Kambhampati and Kapil N. Bhalla
- Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins
